D
Axonics, Inc. AXNX
NASDAQ
Recommendation
Sell
Prev Close
$70.98
Volume
--
Avg Vol (90D)
419,741
Market Cap
$3.63B
Dividend & Yield
--
52-Week Range
$55.09 - $71.05
P/E (TTM)
--
EPS (TTM)
-$0.1153
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
--
Headlines
Reasons to Retain BSX Stock in Your Portfolio for Now
11/19/2024 - Zacks Investment Research
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
11/19/2024 - Zacks Investment Research
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
11/19/2024 - Zacks Investment Research
LMR Partners LLP Trims Holdings in Axonics, Inc. (NASDAQ:AXNX)
11/18/2024 - MarketBeat - AP News
Axonics, Inc. (NASDAQ:AXNX) Sees Large Growth in Short Interest
11/17/2024 - MarketBeat - AP News
Entropy Technologies LP Takes $395,000 Position in Axonics, Inc. (NASDAQ:AXNX)
11/16/2024 - Ticker Report
Boston Scientific (BSX) Completes Acquisition of Axonics
11/16/2024 - GuruFocus
Boston Scientific closes acquisition of Axonics
11/15/2024 - Seeking Alpha - Healthcare
Boston Scientific closes acquisition of Axonics
11/15/2024 - TipRanks Financial Blog
Boston Scientific closes acquisition of Axonics
11/15/2024 - The Fly
Boston Scientific Closes Acquisition of Axonics, Inc.
11/15/2024 - PR Newswire
Axonics, Inc. (NASDAQ:AXNX) Receives Average Rating of "Hold" from Brokerages
11/15/2024 - MarketBeat - AP News
Axonics (AXNX, $70.98) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 14, 2024
11/15/2024 - Tickeron - Stocks
Axonics (AXNX, $70.98) RSI Indicator left the overbought zone on November 14, 2024
11/15/2024 - Tickeron - Stocks
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific
11/14/2024 - Seeking Alpha - Healthcare
Versor Investments LP Has $2.48 Million Stake in Axonics, Inc. (NASDAQ:AXNX)
11/11/2024 - MarketBeat - AP News
Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds
11/9/2024 - Insider Monkey
Needham & Company LLC Reaffirms Hold Rating for Axonics (NASDAQ:AXNX)
11/8/2024 - MarketBeat - AP News
Axonics (AXNX, $70.45) RSI Indicator left the overbought zone on November 07, 2024
11/8/2024 - Tickeron - Stocks
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
11/7/2024 - Zacks Investment Research
Axonics Inc (AXNX) Q3 2024 Earnings: Revenue Hits $116.2 Million, Surpassing Estimates
11/7/2024 - GuruFocus
Axonics reports Q3 EPS 0c, consensus 13c
11/7/2024 - The Fly
Axonics Reports Third Quarter 2024 Financial Results
11/7/2024 - Business Wire
Axonics (AXNX, $70.48) RSI Indicator left the overbought zone on November 06, 2024
11/7/2024 - Tickeron - Technical Analysis
Axonics (AXNX, $70.31) RSI Indicator left the overbought zone on November 05, 2024
11/6/2024 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$431.90M
EBITDA (TTM)
$4.99M
EBIT (TTM)
-$7.50M
Net Income (TTM)
-$5.66M
Balance Sheet
Total Assets (Q)
$774.17M
Total Debt (Q)
$32.51M
Total Liabilities (Q)
$109.68M
Book Value Per Share (Q)
$13.00
Cash Flow
Cash from Operations (TTM)
$14.29M
Cash from Investing (TTM)
$93.27M
Cash from Financing (TTM)
$3.59M
Net Change in Cash (TTM)
$114.21M
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Feb 24 and 28 (est)
Price History
Loading...
Beta
0.94
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jan 05, 2024 - $55.09
52-week High
Nov 14, 2024 - $71.05
Valuation
Market Cap
$3.63B - Mid Cap
Enterprise Value
$3.32B
Price/Sales (TTM)
8.40
Price/Book (Q)
5.46
Dividends and Shares
Shares Outstanding
51.09M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.axonics.com
Phone Number
949 396 6322
Address
26 Technology Drive
Irvine, CA 92618
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation... more
Weiss Ratings